Wilkinson posts a draft chart to guide anaesthesia decisions and notes the evidence is mixed. It is not clear GLP-1 drugs are the focus.
Recap by typeshit. Post by Jonny Wilkinson on X.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.
One writer shares her own unexpected pregnancy while taking the tirzepatide shot, and says many others have been through the same thing.
Cyprus Mail reports that Mounjaro is being added to Gesy coverage, both for diabetes and for adults with obesity.
The $0 benefit needs a new prior approval and still excludes weight loss use. Enrollment for about 1.6 million US associates runs through Nov. 6.
Loading…